JNJ
Price
$161.46
Change
+$0.95 (+0.59%)
Updated
Oct 11 closing price
2 days until earnings call
MRK
Price
$109.73
Change
+$0.33 (+0.30%)
Updated
Oct 11 closing price
18 days until earnings call
Ad is loading...

JNJ vs MRK

Header iconJNJ vs MRK Comparison
Open Charts JNJ vs MRKBanner chart's image
Johnson & Johnson
Price$161.46
Change+$0.95 (+0.59%)
Volume$5.25M
CapitalizationN/A
Merck & Co
Price$109.73
Change+$0.33 (+0.30%)
Volume$8.58M
CapitalizationN/A
View a ticker or compare two or three
JNJ vs MRK Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
JNJ vs. MRK commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Hold and MRK is a StrongSell.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (JNJ: $161.46 vs. MRK: $109.73)
Brand notoriety: JNJ and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 91% vs. MRK: 97%
Market capitalization -- JNJ: $380.22B vs. MRK: $331.75B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 3 FA rating(s) are green whileMRK’s FA Score has 3 green FA rating(s).

  • JNJ’s FA Score: 3 green, 2 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, both JNJ and MRK are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 4 TA indicator(s) are bullish while MRK’s TA Score has 4 bullish TA indicator(s).

  • JNJ’s TA Score: 4 bullish, 6 bearish.
  • MRK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MRK is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +0.73% price change this week, while MRK (@Pharmaceuticals: Major) price change was -0.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

JNJ is expected to report earnings on Jan 28, 2025.

MRK is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than MRK($332B). MRK has higher P/E ratio than JNJ: MRK (935.64) vs JNJ (30.34). JNJ YTD gains are higher at: 5.427 vs. MRK (2.577). JNJ has higher annual earnings (EBITDA): 23.3B vs. MRK (6.91B). JNJ has more cash in the bank: 22.9B vs. MRK (7.09B). JNJ has less debt than MRK: JNJ (29.3B) vs MRK (35.1B). JNJ has higher revenues than MRK: JNJ (85.2B) vs MRK (60.1B).
JNJMRKJNJ / MRK
Capitalization380B332B114%
EBITDA23.3B6.91B337%
Gain YTD5.4272.577211%
P/E Ratio30.34935.643%
Revenue85.2B60.1B142%
Total Cash22.9B7.09B323%
Total Debt29.3B35.1B83%
FUNDAMENTALS RATINGS
JNJ vs MRK: Fundamental Ratings
JNJ
MRK
OUTLOOK RATING
1..100
5859
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
2416
SMR RATING
1..100
2029
PRICE GROWTH RATING
1..100
5261
P/E GROWTH RATING
1..100
8498
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (16) in the Pharmaceuticals Major industry is in the same range as MRK (16). This means that JNJ’s stock grew similarly to MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (16) in the Pharmaceuticals Major industry is in the same range as JNJ (24). This means that MRK’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's SMR Rating (20) in the Pharmaceuticals Major industry is in the same range as MRK (29). This means that JNJ’s stock grew similarly to MRK’s over the last 12 months.

JNJ's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as MRK (61). This means that JNJ’s stock grew similarly to MRK’s over the last 12 months.

JNJ's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as MRK (98). This means that JNJ’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJMRK
RSI
ODDS (%)
Bearish Trend 6 days ago
46%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 4 days ago
43%
Bullish Trend 26 days ago
48%
Declines
ODDS (%)
Bearish Trend 6 days ago
43%
Bearish Trend 5 days ago
46%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
42%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.59%
PFE - JNJ
59%
Loosely correlated
-0.61%
BMY - JNJ
48%
Loosely correlated
-0.38%
ABBV - JNJ
45%
Loosely correlated
-0.08%
GILD - JNJ
41%
Loosely correlated
+0.33%
RHHBY - JNJ
37%
Loosely correlated
+0.80%
More

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+0.30%
AZN - MRK
31%
Poorly correlated
+0.62%
GSK - MRK
24%
Poorly correlated
-0.97%
SNY - MRK
23%
Poorly correlated
+0.35%
JNJ - MRK
22%
Poorly correlated
+0.59%
NVS - MRK
22%
Poorly correlated
+1.23%
More